Long-Term Efficacy and Safety of Fostemsavir among Subgroups of Heavily Treatment-Experienced Adults with HIV-1 - Sorbonne Université
Article Dans Une Revue AIDS Année : 2021

Long-Term Efficacy and Safety of Fostemsavir among Subgroups of Heavily Treatment-Experienced Adults with HIV-1

Dates et versions

hal-03793416 , version 1 (01-10-2022)

Identifiants

Citer

Peter Ackerman, Melanie Thompson, Jean-Michel Molina, Judith Aberg, Isabel Cassetti, et al.. Long-Term Efficacy and Safety of Fostemsavir among Subgroups of Heavily Treatment-Experienced Adults with HIV-1. AIDS, 2021, 35 (7), pp.1061--1072. ⟨10.1097/QAD.0000000000002851⟩. ⟨hal-03793416⟩
10 Consultations
0 Téléchargements

Altmetric

Partager

More